Clearmind Medicine Inc.

Clearmind Medicine Inc.

CMND · Nasdaq

Clearmind Medicine Inc. (CMND) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Clearmind Medicine Inc. in 2026.

Earnings calendar

Next earnings date

Not scheduled

EPS estimate

Revenue estimate

Past earnings

No earnings history available.

Dividend calendar

No dividend history available.

Company profile

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada
Exchange
Nasdaq
CEO
Adi Zuloff-Shani
Employees
4
IPO date
15 Nov 2022
ISIN
CA1850535016
Website
clearmindmedicine.com

Frequently asked questions

Where is Clearmind Medicine Inc. stock listed?

Clearmind Medicine Inc. (CMND) is listed on Nasdaq.